FIELD: pharmacology.
SUBSTANCE: invention is a drug for treatment and prevention of respiratory diseases of the nasal cavity and nasopharynx, consisting of 0.25% oxolinic ointment in an amount of 30.0 mg, tea tree oil in an amount of 0.4 ml, Monarda oil in an amount of 0.4 ml and eucalyptus oil in an amount of 0.1 ml.
EFFECT: complex antiviral, antifungal, antimicrobial, antiinflammatory and antiedematous action, which prolonged effect is ensured by synergism of preparation individual components.
4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT OF SUPPURATIVE RHINOSINUSITIS | 2017 |
|
RU2657512C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF COLD-RELATED DISEASES AND HERPES SIMPLEX, AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373950C1 |
| AGENT FOR APPLYING ORAL AND NASAL CAVITIES AND METHOD FOR ITS USE AS PART OF COMPLEX THERAPY OF INFECTIOUS AND INFLAMMATORY DISEASES OF NASAL AND ORAL CAVITIES | 2021 |
|
RU2762506C1 |
| OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| ANTIVIRAL AGENT - NASAL DROPS "GRIPPFERON" | 1999 |
|
RU2140285C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING LOCAL MANIFESTATIONS OF HERPEX SIMPLEX INFECTIONS AND FOR PREVENTING INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2514103C1 |
| SPRAY FOR EMERGENCY PREVENTION OF ACUTE RESPIRATORY VIRAL INFECTIONS | 2017 |
|
RU2665959C1 |
| COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
| THERAPEUTIC COMPOSITION | 2009 |
|
RU2393871C1 |
